The firm is a life sciences-focused venture capital firm with a global presence and a track record of investing across private and public markets. The firm manages multiple funds backed by institutional and strategic investors and has built a diversified portfolio of companies, including a meaningful number of seed and incubated ventures. The investment team brings extensive experience across venture investing, biopharmaceutical development, academia, and regulatory environments. The firm operates globally with team members based across key innovation hubs in North America and Asia.
The firm invests across the life sciences sector, targeting areas of high unmet medical need. The firm is flexible across geographies and development stages, leveraging a cross-functional platform to support value creation from early company formation through later-stage and public market investing.
From a company and management team perspective, the firm prefers to lead investments and typically takes board representation. The firm plays an active role in supporting portfolio companies through strategic guidance across capital markets, business development, clinical strategy, regulatory planning, and commercialization. The firm seeks to partner with management teams that demonstrate strong capability, commitment, and the ability to advance innovative technologies.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment